Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Pathogenesis, clinical features, and diagnosis of Merkel cell (neuroendocrine) carcinoma

Patricia Tai, MB, BS, DABR, FRCR, FRCPC
Section Editors
Robert S Stern, MD
June K Robinson, MD
Deputy Editor
Rosamaria Corona, MD, DSc


Merkel cell carcinoma (MCC) of the skin is a rare, aggressive cutaneous malignancy that predominantly affects older adults with light skin types and has a propensity for local recurrence and regional lymph node metastases [1]. A variety of other terms have been used to describe this tumor, including neuroendocrine or primary small cell carcinoma of the skin, trabecular cell carcinoma, APUDoma of the skin, and anaplastic cancer of the skin.

The epidemiology, pathogenesis, clinical features, and diagnosis of MCC are discussed here. The staging and treatment of patients with MCC are discussed separately. (See "Staging and treatment of Merkel cell carcinoma".)


Incidence — MCC was first described in 1972 [2]. Data from the Surveillance, Epidemiology and End Results (SEER) Program database indicate that MCC is uncommon; the estimated annual incidence rate in 2006 was 0.6 per 100,000 persons [3]. Incidence rates were higher in males compared with females (0.41 and 0.18 cases per 100,000 person-years, respectively).

Higher incidence rates are reported in Australia and New Zealand [4-6]. Data from the Queensland Cancer Registry indicate an average annual incidence of 1.6 per 100,000 between 2006 and 2010, with a peak rate of 20.7 per 100,000 for individuals 80 years or older [4]. Data from Western Australia between 1993 and 2007 indicate an annual incidence of 0.82 per 100,000 and 15.5 per 100,000 for individuals ≥85 years [6]. An annual incidence of 0.88 per 100,000 has been reported in New Zealand between 2002 and 2011, with a peak rate of 17.6 per 100,000 among individuals ≥85 years [5].

Risk factors — MCC predominantly affects persons with light skin. A study analyzing SEER data from 1973 to 2006 found that 95 percent of cases diagnosed during this interval arose in the white population [3].


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Sat Oct 29 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
  1. Tothill R, Estall V, Rischin D. Merkel cell carcinoma: emerging biology, current approaches, and future directions. Am Soc Clin Oncol Educ Book 2015; :e519.
  2. Toker C. Trabecular carcinoma of the skin. Arch Dermatol 1972; 105:107.
  3. Albores-Saavedra J, Batich K, Chable-Montero F, et al. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol 2010; 37:20.
  4. Youlden DR, Soyer HP, Youl PH, et al. Incidence and survival for Merkel cell carcinoma in Queensland, Australia, 1993-2010. JAMA Dermatol 2014; 150:864.
  5. Robertson JP, Liang ES, Martin RC. Epidemiology of Merkel cell carcinoma in New Zealand: a population-based study. Br J Dermatol 2015; 173:835.
  6. Girschik J, Thorn K, Beer TW, et al. Merkel cell carcinoma in Western Australia: a population-based study of incidence and survival. Br J Dermatol 2011; 165:1051.
  7. Clarke CA, Robbins HA, Tatalovich Z, et al. Risk of merkel cell carcinoma after solid organ transplantation. J Natl Cancer Inst 2015; 107.
  8. Penn I, First MR. Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation 1999; 68:1717.
  9. Tadmor T, Aviv A, Polliack A. Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: an old bond with possible new viral ties. Ann Oncol 2011; 22:250.
  10. Engels EA, Frisch M, Goedert JJ, et al. Merkel cell carcinoma and HIV infection. Lancet 2002; 359:497.
  11. Manganoni MA, Farisoglio C, Tucci G, et al. Merkel cell carcinoma and HIV infection: a case report and review of the literature. AIDS Patient Care STDS 2007; 21:447.
  12. Howard RA, Dores GM, Curtis RE, et al. Merkel cell carcinoma and multiple primary cancers. Cancer Epidemiol Biomarkers Prev 2006; 15:1545.
  13. Heath M, Jaimes N, Lemos B, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol 2008; 58:375.
  14. Kaae J, Hansen AV, Biggar RJ, et al. Merkel cell carcinoma: incidence, mortality, and risk of other cancers. J Natl Cancer Inst 2010; 102:793.
  15. Koljonen V, Kukko H, Pukkala E, et al. Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. Br J Cancer 2009; 101:1444.
  16. Ratner D, Nelson BR, Brown MD, Johnson TM. Merkel cell carcinoma. J Am Acad Dermatol 1993; 29:143.
  17. Tilling T, Moll I. Which are the cells of origin in merkel cell carcinoma? J Skin Cancer 2012; 2012:680410.
  18. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319:1096.
  19. Kassem A, Schöpflin A, Diaz C, et al. Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res 2008; 68:5009.
  20. Sharp CP, Norja P, Anthony I, et al. Reactivation and mutation of newly discovered WU, KI, and Merkel cell carcinoma polyomaviruses in immunosuppressed individuals. J Infect Dis 2009; 199:398.
  21. Carter JJ, Paulson KG, Wipf GC, et al. Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst 2009; 101:1510.
  22. Leroux-Kozal V, Lévêque N, Brodard V, et al. Merkel cell carcinoma: histopathologic and prognostic features according to the immunohistochemical expression of Merkel cell polyomavirus large T antigen correlated with viral load. Hum Pathol 2015; 46:443.
  23. Santos-Juanes J, Fernández-Vega I, Fuentes N, et al. Merkel cell carcinoma and Merkel cell polyomavirus: a systematic review and meta-analysis. Br J Dermatol 2015; 173:42.
  24. Rodig SJ, Cheng J, Wardzala J, et al. Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus. J Clin Invest 2012; 122:4645.
  25. Martel-Jantin C, Filippone C, Tortevoye P, et al. Molecular epidemiology of merkel cell polyomavirus: evidence for geographically related variant genotypes. J Clin Microbiol 2014; 52:1687.
  26. Schowalter RM, Pastrana DV, Pumphrey KA, et al. Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe 2010; 7:509.
  27. Viscidi RP, Rollison DE, Sondak VK, et al. Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus. Clin Vaccine Immunol 2011; 18:1737.
  28. Martel-Jantin C, Pedergnana V, Nicol JT, et al. Merkel cell polyomavirus infection occurs during early childhood and is transmitted between siblings. J Clin Virol 2013; 58:288.
  29. Chen T, Hedman L, Mattila PS, et al. Serological evidence of Merkel cell polyomavirus primary infections in childhood. J Clin Virol 2011; 50:125.
  30. Sastre-Garau X, Peter M, Avril MF, et al. Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis. J Pathol 2009; 218:48.
  31. Church CD, Nghiem P. How does the Merkel polyomavirus lead to a lethal cancer? Many answers, many questions, and a new mouse model. J Invest Dermatol 2015; 135:1221.
  32. DeCaprio JA, Garcea RL. A cornucopia of human polyomaviruses. Nat Rev Microbiol 2013; 11:264.
  33. Erstad DJ, Jr JC. Mutational analysis of merkel cell carcinoma. Cancers (Basel) 2014; 6:2116.
  34. Foulongne V, Dereure O, Kluger N, et al. Merkel cell polyomavirus DNA detection in lesional and nonlesional skin from patients with Merkel cell carcinoma or other skin diseases. Br J Dermatol 2010; 162:59.
  35. Kassem A, Technau K, Kurz AK, et al. Merkel cell polyomavirus sequences are frequently detected in nonmelanoma skin cancer of immunosuppressed patients. Int J Cancer 2009; 125:356.
  36. Rollison DE, Giuliano AR, Messina JL, et al. Case-control study of Merkel cell polyomavirus infection and cutaneous squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2012; 21:74.
  37. Murakami M, Imajoh M, Ikawa T, et al. Presence of Merkel cell polyomavirus in Japanese cutaneous squamous cell carcinoma. J Clin Virol 2011; 50:37.
  38. Dworkin AM, Tseng SY, Allain DC, et al. Merkel cell polyomavirus in cutaneous squamous cell carcinoma of immunocompetent individuals. J Invest Dermatol 2009; 129:2868.
  39. Trizuljak J, Srovnal J, Plevová K, et al. Analysis of prognostic significance of merkel cell polyomavirus in chronic lymphocytic leukemia. Clin Lymphoma Myeloma Leuk 2015; 15:439.
  40. Du-Thanh A, Dereure O, Guillot B, Foulongne V. Merkel cell polyomavirus: its putative involvement in a particular subset of cutaneous lymphoma with possibly unfavorable outcome. J Clin Virol 2014; 61:161.
  41. Reisinger DM, Shiffer JD, Cognetta AB Jr, et al. Lack of evidence for basal or squamous cell carcinoma infection with Merkel cell polyomavirus in immunocompetent patients with Merkel cell carcinoma. J Am Acad Dermatol 2010; 63:400.
  42. Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev 1999; 8:153.
  43. Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol 2003; 49:832.
  44. Zhan FQ, Packianathan VS, Zeitouni NC. Merkel cell carcinoma: a review of current advances. J Natl Compr Canc Netw 2009; 7:333.
  45. Lunder EJ, Stern RS. Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation. N Engl J Med 1998; 339:1247.
  46. Van Gele M, Kaghad M, Leonard JH, et al. Mutation analysis of P73 and TP53 in Merkel cell carcinoma. Br J Cancer 2000; 82:823.
  47. Popp S, Waltering S, Herbst C, et al. UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas. Int J Cancer 2002; 99:352.
  48. Dabner M, McClure RJ, Harvey NT, et al. Merkel cell polyomavirus and p63 status in Merkel cell carcinoma by immunohistochemistry: Merkel cell polyomavirus positivity is inversely correlated with sun damage, but neither is correlated with outcome. Pathology 2014; 46:205.
  49. Bajetta E, Platania M, Catena L, et al. Merkel cell carcinoma after liver transplantation: a case report. Tumori 2007; 93:323.
  50. Bensaleh H, Perney P, Dereure O, et al. Merkel cell carcinoma in a liver transplant patient. Am J Clin Dermatol 2007; 8:239.
  51. Koljonen V, Kukko H, Tukiainen E, et al. Incidence of Merkel cell carcinoma in renal transplant recipients. Nephrol Dial Transplant 2009; 24:3231.
  52. Perrett CM, Walker SL, O'Donovan P, et al. Azathioprine treatment photosensitizes human skin to ultraviolet A radiation. Br J Dermatol 2008; 159:198.
  53. O'Donovan P, Perrett CM, Zhang X, et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005; 309:1871.
  54. Han W, Soltani K, Ming M, He YY. Deregulation of XPC and CypA by cyclosporin A: an immunosuppression-independent mechanism of skin carcinogenesis. Cancer Prev Res (Phila) 2012; 5:1155.
  55. Han W, Ming M, He TC, He YY. Immunosuppressive cyclosporin A activates AKT in keratinocytes through PTEN suppression: implications in skin carcinogenesis. J Biol Chem 2010; 285:11369.
  56. Ming M, Zhao B, Qiang L, He YY. Effect of immunosuppressants tacrolimus and mycophenolate mofetil on the keratinocyte UVB response. Photochem Photobiol 2015; 91:242.
  57. Cimino PJ, Robirds DH, Tripp SR, et al. Retinoblastoma gene mutations detected by whole exome sequencing of Merkel cell carcinoma. Mod Pathol 2014; 27:1073.
  58. Harms PW, Patel RM, Verhaegen ME, et al. Distinct gene expression profiles of viral- and nonviral-associated merkel cell carcinoma revealed by transcriptome analysis. J Invest Dermatol 2013; 133:936.
  59. Greenberg ES, Chong KK, Huynh KT, et al. Epigenetic biomarkers in skin cancer. Cancer Lett 2014; 342:170.
  60. Veija T, Sahi H, Koljonen V, et al. miRNA-34a underexpressed in Merkel cell polyomavirus-negative Merkel cell carcinoma. Virchows Arch 2015; 466:289.
  61. Sihto H, Kukko H, Koljonen V, et al. Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma. Clin Cancer Res 2011; 17:4806.
  62. Harms PW, Vats P, Verhaegen ME, et al. The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma. Cancer Res 2015; 75:3720.
  63. Higaki-Mori H, Kuwamoto S, Iwasaki T, et al. Association of Merkel cell polyomavirus infection with clinicopathological differences in Merkel cell carcinoma. Hum Pathol 2012; 43:2282.
  64. Haymerle G, Fochtmann A, Kunstfeld R, et al. Management of Merkel cell carcinoma of unknown primary origin: the Vienna Medical School experience. Eur Arch Otorhinolaryngol 2015; 272:425.
  65. Asgari MM, Sokil MM, Warton EM, et al. Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma. JAMA Dermatol 2014; 150:716.
  66. Deneve JL, Messina JL, Marzban SS, et al. Merkel cell carcinoma of unknown primary origin. Ann Surg Oncol 2012; 19:2360.
  67. Jalilian C, Chamberlain AJ, Haskett M, et al. Clinical and dermoscopic characteristics of Merkel cell carcinoma. Br J Dermatol 2013; 169:294.
  68. Harting MS, Ludgate MW, Fullen DR, et al. Dermatoscopic vascular patterns in cutaneous Merkel cell carcinoma. J Am Acad Dermatol 2012; 66:923.
  69. Dalle S, Parmentier L, Moscarella E, et al. Dermoscopy of Merkel cell carcinoma. Dermatology 2012; 224:140.
  70. Scalvenzi M, Palmisano F, Ilardi G, et al. Clinical, dermoscopic and histological features of a Merkel cell carcinoma of the hand. J Dermatol Case Rep 2013; 7:15.
  71. Wong HH, Wang J. Merkel cell carcinoma. Arch Pathol Lab Med 2010; 134:1711.
  72. Warner TF, Uno H, Hafez GR, et al. Merkel cells and Merkel cell tumors. Ultrastructure, immunocytochemistry and review of the literature. Cancer 1983; 52:238.
  73. Martin B, Poblet E, Rios JJ, et al. Merkel cell carcinoma with divergent differentiation: histopathological and immunohistochemical study of 15 cases with PCR analysis for Merkel cell polyomavirus. Histopathology 2013; 62:711.
  74. Saeb-Lima M, Montante-Montes de Oca D, Albores-Saavedra J. Merkel cell carcinoma with eccrine differentiation: a clinicopathologic study of 7 cases. Ann Diagn Pathol 2008; 12:410.
  75. Narisawa Y, Koba S, Inoue T, Nagase K. Histogenesis of pure and combined Merkel cell carcinomas: An immunohistochemical study of 14 cases. J Dermatol 2015; 42:445.
  76. Pulitzer MP, Brannon AR, Berger MF, et al. Cutaneous squamous and neuroendocrine carcinoma: genetically and immunohistochemically different from Merkel cell carcinoma. Mod Pathol 2015; 28:1023.
  77. Chan JK, Suster S, Wenig BM, et al. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 1997; 21:226.
  78. Leonard JH, Leonard P, Kearsley JH. Chromosomes 1, 11, and 13 are frequently involved in karyotypic abnormalities in metastatic Merkel cell carcinoma. Cancer Genet Cytogenet 1993; 67:65.
  79. Van Gele M, Speleman F, Vandesompele J, et al. Characteristic pattern of chromosomal gains and losses in Merkel cell carcinoma detected by comparative genomic hybridization. Cancer Res 1998; 58:1503.
  80. Sozzi G, Bertoglio MG, Pilotti S, et al. Cytogenetic studies in primary and metastatic neuroendocrine Merkel cell carcinoma. Cancer Genet Cytogenet 1988; 30:151.
  81. Van Gele M, Van Roy N, Ronan SG, et al. Molecular analysis of 1p36 breakpoints in two Merkel cell carcinomas. Genes Chromosomes Cancer 1998; 23:67.
  82. Swick BL, Srikantha R, Messingham KN. Specific analysis of KIT and PDGFR-alpha expression and mutational status in Merkel cell carcinoma. J Cutan Pathol 2013; 40:623.
  83. Iwasaki T, Matsushita M, Nonaka D, et al. Comparison of Akt/mTOR/4E-BP1 pathway signal activation and mutations of PIK3CA in Merkel cell polyomavirus-positive and Merkel cell polyomavirus-negative carcinomas. Hum Pathol 2015; 46:210.
  84. Xie H, Lee L, Caramuta S, et al. MicroRNA expression patterns related to merkel cell polyomavirus infection in human merkel cell carcinoma. J Invest Dermatol 2014; 134:507.
  85. Daoud MA, Mete O, Al Habeeb A, Ghazarian D. Neuroendocrine carcinoma of the skin--an updated review. Semin Diagn Pathol 2013; 30:234.
  86. Pulitzer MP, Amin BD, Busam KJ. Merkel cell carcinoma: review. Adv Anat Pathol 2009; 16:135.
  87. Sibley RK, Dehner LP, Rosai J. Primary neuroendocrine (Merkel cell?) carcinoma of the skin. I. A clinicopathologic and ultrastructural study of 43 cases. Am J Surg Pathol 1985; 9:95.
  88. Meyer-Pannwitt U, Kummerfeldt K, Boubaris P, Caselitz J. [Merkel cell tumor or neuroendocrine skin carcinoma]. Langenbecks Arch Chir 1997; 382:349.
  89. Leech SN, Kolar AJ, Barrett PD, et al. Merkel cell carcinoma can be distinguished from metastatic small cell carcinoma using antibodies to cytokeratin 20 and thyroid transcription factor 1. J Clin Pathol 2001; 54:727.
  90. Song HS, Kim YC. Small cell melanoma. Ann Dermatol 2014; 26:419.
  91. House NS, Fedok F, Maloney ME, Helm KF. Malignant melanoma with clinical and histologic features of Merkel cell carcinoma. J Am Acad Dermatol 1994; 31:839.
  92. Moshiri AS, Nghiem P. Milestones in the staging, classification, and biology of Merkel cell carcinoma. J Natl Compr Canc Netw 2014; 12:1255.
  93. Andea AA, Coit DG, Amin B, Busam KJ. Merkel cell carcinoma: histologic features and prognosis. Cancer 2008; 113:2549.
  94. Fields RC, Busam KJ, Chou JF, et al. Five hundred patients with Merkel cell carcinoma evaluated at a single institution. Ann Surg 2011; 254:465.
  95. Paulson KG, Iyer JG, Tegeder AR, et al. Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J Clin Oncol 2011; 29:1539.
  96. Sihto H, Kukko H, Koljonen V, et al. Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J Natl Cancer Inst 2009; 101:938.
  97. Asioli S, Righi A, de Biase D, et al. Expression of p63 is the sole independent marker of aggressiveness in localised (stage I-II) Merkel cell carcinomas. Mod Pathol 2011; 24:1451.
  98. Stetsenko GY, Malekirad J, Paulson KG, et al. p63 expression in Merkel cell carcinoma predicts poorer survival yet may have limited clinical utility. Am J Clin Pathol 2013; 140:838.
  99. Touzé A, Le Bidre E, Laude H, et al. High levels of antibodies against merkel cell polyomavirus identify a subset of patients with merkel cell carcinoma with better clinical outcome. J Clin Oncol 2011; 29:1612.
  100. Samimi M, Molet L, Fleury M, et al. Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinoma. Br J Dermatol 2016; 174:813.
  101. Liang E, Brower JV, Rice SR, et al. Merkel Cell Carcinoma Analysis of Outcomes: A 30-Year Experience. PLoS One 2015; 10:e0129476.